Table 3.
N = 248 | N = 6 | |||||
---|---|---|---|---|---|---|
Variables | Preop. | At 1‐y follow‐up | P value* | Preop. excluded | 1‐y excluded | P value* |
Aa | 1.17 ± 1.07 | −2.04 ± 0.96 | <0.001 | 1.00 ± 1.67 | −2.33 ± 0.82 | 0.027 |
Ba | 1.67 ± 1.56 | −2.16 ± 0.88 | <0.001 | 1.83 ± 1.47 | −2.33 ± 0.82 | 0.026 |
C | −0.99 ± 3.59 | −5.36 ± 3.18 | <0.001 | 0.00 ± 2.28 | −5.00 ± 4.15 | 0.026 |
Ap | −1.48 ± 1.27 | −1.65 ± 1.15 | 0.144 | −1.50 ± 0.55 | −2.17 ± 0.75 | 0.157 |
Bp | −1.47 ± 1.50 | −1.69 ± 1.19 | 0.205 | −1.67 ± 0.52 | −2.17 ± 0.75 | 0.180 |
TVL | 8.81 ± 1.46 | 9.18 ± 1.69 | <0.001 | 8.83 ± 1.72 | 9.67 ± 1.03 | 0.102 |
GH | 4.51 ± 1.18 | 4.16 ± 1.26 | <0.001 | 5.00 ± 0.89 | 4.67 ± 1.03 | 0.157 |
Abbreviations: POP‐Q, Pelvic Organ Prolapse Quantification System; Preop, preoperatively.
Data are shown as mean ± SD. POP‐Q measurements as defined by IUGA‐ICS prolapse staging.
The Wilcoxon signed‐rank test for matched pairs.